Website maintenance took place on Thursday 30 April 2026. If you experience any issues, please contact us.
Notice for selinexor (Antengene (AUS) Pty Ltd)
Active ingredients
selinexor
Sponsor
Date of review outcome
Lapse date
Type
Orphan drug
Dosage form(s)
Film-coated tablet
Indication
For the treatment of diffuse large B-Cell lymphoma
Therapeutic area
Haematology